Cargando…

Clinical and prognostic role of sarcopenia in elderly patients with classical Hodgkin lymphoma: a multicentre experience

BACKGROUND: Elderly classical Hodgkin lymphoma (cHL) (ecHL) is a rare disease with dismal prognosis and no standard treatment. Fitness‐based approaches may help design appropriate treatments. Sarcopenia has been associated with an increased risk of treatment‐related toxicities and worse survival in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zilioli, Vittorio Ruggero, Albano, Domenico, Arcari, Annalisa, Merli, Francesco, Coppola, Alessandra, Besutti, Giulia, Marcheselli, Luigi, Gramegna, Doriana, Muzi, Cristina, Manicone, Moana, Camalori, Manuela, Ciammella, Patrizia, Colloca, Giuseppe, Tucci, Alessandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350211/ https://www.ncbi.nlm.nih.gov/pubmed/34114749 http://dx.doi.org/10.1002/jcsm.12736

Ejemplares similares

Comparison between skeletal muscle and adipose tissue measurements with high-dose CT and low-dose attenuation correction CT of (18)F-FDG PET/CT in elderly Hodgkin lymphoma patients: a two-centre validation
por: Albano, Domenico, et al.
Publicado: (2021)

Current Treatment Options and the Role of Functional Status Assessment in Classical Hodgkin Lymphoma in Older Adults: A Review
por: Zilioli, Vittorio Ruggero, et al.
Publicado: (2023)

Brentuximab vedotin consolidation after autologous stem cell transplantation for Hodgkin lymphoma: A Fondazione Italiana Linfomi real‐life experience
por: Massaro, Fulvio, et al.
Publicado: (2021)

Safety and efficacy of netupitant/palonosetron and dexamethasone in classical Hodgkin’s lymphoma patients with inadequate chemotherapy-induced nausea and vomiting prophylaxis with palonosetron and dexamethasone: a single-center real-life experience
por: Zilioli, Vittorio R, et al.
Publicado: (2020)

P1070: DECISIONAL ROLE OF INTERIM PET IN RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA TREATED WITH BEGEV CHEMOTHERAPY AS FIRST SALVAGE
por: Rusconi, Chiara, et al.
Publicado: (2023)

Diffuse large B-cell lymphoma in octogenarians aged 85 and older can benefit from treatment with curative intent: a report on 129 patients prospectively registered in the Elderly Project of the Fondazione Italiana Linfomi (FIL)
por: Tucci, Alessandra, et al.
Publicado: (2022)

P105: Decisional role of interim PET in relapsed/refractory classical Hodgkin Lymphoma treated with four begev cycles
por: Rusconi, Chiara, et al.
Publicado: (2022)

Clinical Management of Long-Term Survivors after Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma
por: Bari, Alessia, et al.
Publicado: (2022)

Prognostic Role of Pre-Treatment Metabolic Parameters and Sarcopenia Derived by 2-[(18)F]-FDG PET/CT in Elderly Mantle Cell Lymphoma
por: Albano, Domenico, et al.
Publicado: (2022)

The classic prognostic factors in advanced Hodgkin’s lymphoma patients are losing their meaning at the time of Pet-guided treatments
por: Bari, Alessia, et al.
Publicado: (2019)

Longitudinal Body Composition Changes Detected by [(18)F]FDG PET/CT during and after Chemotherapy and Their Prognostic Role in Elderly Hodgkin Lymphoma
por: Albano, Domenico, et al.
Publicado: (2022)

Adenoid Cystic Carcinoma/Basal Cell Carcinoma of the Prostate: Overview and Update on Rare Prostate Cancer Subtypes
por: Cozzi, Salvatore, et al.
Publicado: (2022)

A Fondazione Italiana Linfomi cohort study of R-COMP vs R-CHOP in older patients with diffuse large B-cell lymphoma
por: Arcari, Annalisa, et al.
Publicado: (2023)

HBV Reactivation in Patients with Past Infection Affected by Non-Hodgkin Lymphoma and Treated with Anti-CD20 Antibody Based Immuno-Chemotherapy: A Multicenter Experience
por: Clerico, Michele, et al.
Publicado: (2022)

Therapy-Related Myeloid Neoplasm in Non-Hodgkin Lymphoma Survivors
por: Bari, Alessia, et al.
Publicado: (2011)

Absolute monocyte count at diagnosis could improve the prognostic role of early FDG‐PET in classical Hodgkin lymphoma patients
por: Bari, Alessia, et al.
Publicado: (2016)

Immunological Deregulation in Classic Hodgkin Lymphoma
por: Romano, Alessandra, et al.
Publicado: (2014)

Editorial: Morphological and functional imaging: a combined approach
por: Albano, Domenico, et al.
Publicado: (2023)

BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma: a real-life experience
por: Stefoni, Vittorio, et al.
Publicado: (2022)

Impact of Sarcopenia on Outcome of Exercise Therapy in Older Non-Hodgkin Lymphoma Patients
por: Kasahara, Ryuichi, et al.
Publicado: (2023)

The prognostic value of the myeloid-mediated immunosuppression marker Arginase-1 in classic Hodgkin lymphoma
por: Romano, Alessandra, et al.
Publicado: (2016)

Romidepsin-CHOEP followed by high-dose chemotherapy and stem-cell transplantation in untreated Peripheral T-Cell Lymphoma: results of the PTCL13 phase Ib/II study
por: Chiappella, Annalisa, et al.
Publicado: (2023)

The potential of classic and specific bioelectrical impedance vector analysis for the assessment of sarcopenia and sarcopenic obesity
por: Marini, Elisabetta, et al.
Publicado: (2012)

P006: Clinical outcome of classical Hodgkin Lymphoma patients receiving systemic anti-lymphoma treatment during SARS-COV-2 positivity: Results from the chemo-covid study on behalf of fondazione italiana linfomi
por: Rusconi, Chiara, et al.
Publicado: (2022)

Pediatric sarcopenia: exploring a new concept in children with chronic liver disease()()
por: Merli, Manuela
Publicado: (2019)

Genetics of classical Hodgkin Lymphoma
por: Schiavoni, Gianluca, et al.
Publicado: (2018)

Kinetics of Circulating Plasma Cell-Free DNA in Paediatric Classical Hodgkin Lymphoma
por: Primerano, Simona, et al.
Publicado: (2016)

Sarcopenia Diagnosis and Management in Hematological Malignancies and Differences with Cachexia and Frailty
por: Colloca, Giuseppe Ferdinando, et al.
Publicado: (2023)

Sarcopenia Is Associated With Development of Acute-on-Chronic Liver Failure in Decompensated Liver Cirrhosis Receiving Transjugular Intrahepatic Portosystemic Shunt
por: Praktiknjo, Michael, et al.
Publicado: (2019)

Pegfilgrastim in Supportive Care of Hodgkin Lymphoma
por: Cerchione, Claudio, et al.
Publicado: (2022)

Sarcopenia: imaging assessment and clinical application
por: Chianca, Vito, et al.
Publicado: (2021)

The real risk of secondary non-Hodgkin lymphoma following classical Hodgkin lymphoma
por: Dogan, Ahmet
Publicado: (2022)

The molecular mechanisms of classic Hodgkin's lymphoma.
por: Felberbaum, Rachael S.
Publicado: (2005)

Controversies in the Treatment of Classical Hodgkin Lymphoma
por: Eichenauer, Dennis A., et al.
Publicado: (2018)

The Grey Zones of Classic Hodgkin Lymphoma
por: Bosch-Schips, Jan, et al.
Publicado: (2022)

Outcome of Children and Adolescents with Recurrent Classical Hodgkin Lymphoma: The Italian Experience
por: Garaventa, Alberto, et al.
Publicado: (2022)

Prevalence of Sarcopenia in Older Patients in Rehabilitation Wards
por: Brugliera, Luigia, et al.
Publicado: (2023)

Long-term follow-up of rituximab plus bendamustine and cytarabine in older patients with newly diagnosed MCL
por: Tisi, Maria Chiara, et al.
Publicado: (2023)

Allogeneic Stem Cell Transplantation in Mantle Cell Lymphoma in the Era of New Drugs and CAR-T Cell Therapy
por: Marangon, Miriam, et al.
Publicado: (2021)

Nutrition and microRNAs: Novel Insights to Fight Sarcopenia
por: Barbiera, Alessandra, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_uq903dqdf7aoigo3lktgntru7e